Assertio Quarterly Income Statements Chart
Quarterly
|
Annual
Assertio Quarterly Income Statements Table
Quarterly
|
Annual
| Unit: USD | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| revenues: | ||||||||||||||||
| product sales | 31,862,000 | 32,462,000 | 35,137,000 | 40,083,000 | 41,769,000 | 49,863,000 | 34,279,000 | 35,430,000 | 35,546,000 | 32,149,000 | 25,997,000 | 24,831,000 | 26,405,000 | 29,815,000 | 34,266,000 | 20,165,000 |
| royalties and milestones | 586,000 | 523,000 | 490,000 | 723,000 | 697,000 | 487,000 | 473,000 | 451,000 | 992,000 | 1,188,000 | 416,000 | 542,000 | 434,000 | 361,000 | 299,000 | 452,000 |
| total revenues | 32,448,000 | 32,985,000 | 35,627,000 | 40,991,000 | 42,466,000 | 50,350,000 | 34,212,000 | 35,131,000 | 36,538,000 | 33,328,000 | 25,472,000 | 25,373,000 | 26,839,000 | 30,176,000 | 34,565,000 | 20,617,000 |
| yoy | -23.59% | -34.49% | 4.14% | 16.68% | 16.22% | 51.07% | 34.31% | 38.46% | 36.14% | 10.45% | -26.31% | 23.07% | ||||
| qoq | -1.63% | -7.42% | -13.09% | -3.47% | -15.66% | 47.17% | -2.62% | -3.85% | 9.63% | 30.84% | 0.39% | -5.46% | -11.06% | -12.70% | 67.65% | |
| costs and expenses: | ||||||||||||||||
| cost of sales | 11,177,000 | 9,721,000 | 7,060,000 | 4,772,000 | 5,467,000 | 6,014,000 | 4,009,000 | 4,528,000 | 4,195,000 | 4,896,000 | 3,050,000 | 3,921,000 | 3,966,000 | 6,773,000 | 6,462,000 | 5,238,000 |
| gross profit | 21,271,000 | 23,264,000 | 28,567,000 | 36,219,000 | 36,999,000 | 44,336,000 | 30,203,000 | 30,603,000 | 32,343,000 | 28,432,000 | 22,422,000 | 21,452,000 | 22,873,000 | 23,403,000 | 28,103,000 | 15,379,000 |
| yoy | -42.51% | -47.53% | -5.42% | 18.35% | 14.40% | 55.94% | 34.70% | 42.66% | 41.40% | 21.49% | -20.21% | 39.49% | ||||
| qoq | -8.57% | -18.56% | -21.13% | -2.11% | -16.55% | 46.79% | -1.31% | -5.38% | 13.76% | 26.80% | 4.52% | -6.21% | -2.26% | -16.72% | 82.74% | |
| gross margin % | 65.55% | 70.53% | 80.18% | 88.36% | 87.13% | 88.06% | 88.28% | 87.11% | 88.52% | 85.31% | 88.03% | 84.55% | 85.22% | 77.56% | 81.30% | 74.59% |
| research and development expenses | 733,000 | 1,024,000 | 1,316,000 | 503,000 | 230,000 | 1,316,000 | 1,626,000 | |||||||||
| selling, general and administrative expenses | 18,524,000 | 23,958,000 | 21,005,000 | 16,771,000 | 16,904,000 | 13,702,000 | 11,900,000 | 10,543,000 | 10,638,000 | 13,276,000 | 9,313,000 | 26,235,000 | 7,730,000 | 23,133,000 | 25,746,000 | 28,131,000 |
| change in fair value of contingent consideration | -17,414,000 | -17,532,000 | 241,000 | -465,250 | -1,861,000 | |||||||||||
| amortization of intangible assets | 5,631,000 | 4,775,000 | 10,184,000 | 6,284,000 | 6,284,000 | 8,170,000 | 7,969,000 | 7,969,000 | 8,501,000 | 7,175,000 | 7,175,000 | 7,218,000 | 6,547,000 | 6,546,000 | 5,587,000 | 4,855,000 |
| restructuring charges | 720,000 | 2,442,000 | 3,034,000 | 1,089,000 | 11,019,000 | 268,000 | 6,519,000 | |||||||||
| total costs and expenses | 36,785,000 | 65,314,000 | 263,898,000 | 28,571,000 | 37,822,000 | 39,728,000 | 27,778,000 | 24,340,000 | 24,979,000 | 25,347,000 | 19,538,000 | 37,374,000 | 19,332,000 | 65,133,000 | 39,379,000 | 46,369,000 |
| income from operations | -4,337,000 | -32,329,000 | -228,271,000 | 12,420,000 | 4,644,000 | 10,622,000 | 6,434,000 | 10,791,000 | 11,559,000 | 7,981,000 | 5,934,000 | -12,001,000 | 7,507,000 | -34,957,000 | -4,814,000 | -25,752,000 |
| yoy | -193.39% | -404.36% | -3647.89% | 15.10% | -59.82% | 33.09% | 8.43% | -189.92% | 53.98% | -122.83% | -223.27% | -53.40% | ||||
| qoq | -86.58% | -85.84% | -1937.93% | 167.44% | -56.28% | 65.09% | -40.38% | -6.64% | 44.83% | 34.50% | -149.45% | -259.86% | -121.47% | 626.15% | -81.31% | |
| operating margin % | -13.37% | -98.01% | -640.72% | 30.30% | 10.94% | 21.10% | 18.81% | 30.72% | 31.64% | 23.95% | 23.30% | -47.30% | 27.97% | -115.84% | -13.93% | -124.91% |
| other income: | ||||||||||||||||
| debt-related expenses | -2,479,500 | -9,918,000 | ||||||||||||||
| interest expense | -757,000 | -755,000 | -752,000 | -751,000 | -1,122,000 | -1,313,000 | -2,052,000 | -2,269,000 | -2,327,000 | -2,437,000 | -2,495,000 | -2,605,000 | -2,684,000 | -2,598,000 | -3,050,000 | -1,604,000 |
| other gain | 716,000 | 1,179,000 | 138,000 | 661,000 | 802,000 | -731,000 | 2,000 | -95,000 | 545,000 | -504,000 | 344,000 | 137,000 | 269,000 | 346,000 | 253,000 | |
| total other income | -41,000 | 424,000 | -614,000 | -90,000 | -10,238,000 | -2,044,000 | -2,050,000 | -2,364,000 | -1,782,000 | -2,941,000 | -2,151,000 | -2,468,000 | -2,415,000 | -391,000 | -4,658,000 | -18,219,000 |
| net income before income taxes | -4,378,000 | -31,905,000 | -228,885,000 | 12,330,000 | -5,594,000 | 8,578,000 | 4,384,000 | 8,427,000 | 9,777,000 | 5,040,000 | 3,783,000 | -14,469,000 | 5,092,000 | -35,348,000 | -9,472,000 | -43,971,000 |
| income tax benefit | -132,000 | 2,110,000 | -593,000 | -434,000 | -46,000 | 300,000 | 10,995,000 | -1,050,000 | 9,472,000 | |||||||
| net income and comprehensive loss | -4,510,000 | -57,384,000 | -279,544,000 | 8,470,000 | -3,484,000 | 88,553,000 | 4,174,000 | 7,834,000 | 9,064,000 | 4,606,000 | 3,737,000 | -14,169,000 | 4,544,000 | -24,353,000 | -10,522,000 | -34,499,000 |
| yoy | 29.45% | -164.80% | -6797.27% | 8.12% | -138.44% | 1822.56% | 11.69% | -155.29% | 99.47% | -118.91% | -135.52% | -58.93% | ||||
| qoq | -92.14% | -79.47% | -3400.40% | -343.11% | -103.93% | 2021.54% | -46.72% | -13.57% | 96.79% | 23.25% | -126.37% | -411.82% | -118.66% | 131.45% | -69.50% | |
| net income margin % | -13.90% | -173.97% | -784.64% | 20.66% | -8.20% | 175.87% | 12.20% | 22.30% | 24.81% | 13.82% | 14.67% | -55.84% | 16.93% | -80.70% | -30.44% | -167.33% |
| basic and diluted net income per share | -0.05 | -0.01 | -0.09 | |||||||||||||
| shares used in computing basic and diluted net income per share | 94,980 | 24,958 | 119,564 | |||||||||||||
| other revenue | 185,000 | -540,000 | -750,000 | -9,000 | -941,000 | |||||||||||
| loss on impairment of intangible assets | 40,808,000 | 238,831,000 | ||||||||||||||
| income tax expense | -13,102,250 | -50,659,000 | -3,860,000 | -379,000 | -210,000 | -713,000 | -548,000 | |||||||||
| basic net income per share | -0.32 | -3.42 | 0.15 | -0.07 | 1.88 | 0.09 | 0.17 | 0.2 | 0.11 | 0.08 | -0.32 | 0.03 | -0.35 | |||
| diluted net income per share | -0.32 | -3.42 | 0.13 | -0.07 | 1.61 | 0.08 | 0.16 | 0.2 | 0.11 | 0.08 | -0.32 | 0.03 | -0.35 | |||
| shares used in computing basic net income per share | 7,965 | 81,713 | 56,142 | 51,005 | 438 | 48,180 | 46,274 | 45,204 | 619 | 44,969 | 44,706 | 151,296 | 98,558 | |||
| shares used in computing diluted net income per share | 7,965 | 81,713 | 70,144 | 51,005 | 4,199 | 57,386 | 47,579 | 46,127 | 619 | 45,055 | 44,706 | 153,918 | 98,558 | |||
| fair value of contingent consideration | 9,167,000 | 11,842,000 | 3,900,000 | 1,300,000 | 1,645,000 | |||||||||||
| commercialization agreement | ||||||||||||||||
| other income : | ||||||||||||||||
| gain on sale of gralise | -850,000 | |||||||||||||||
| loss on extinguishment of convertible notes | -16,272,000 | |||||||||||||||
| loss on sale of nucynta | ||||||||||||||||
| loss on debt extinguishment | ||||||||||||||||
| gain on sale of nucynta | 1,006,000 | |||||||||||||||
| gain on extinguishment of convertible notes | -11,970,000 | |||||||||||||||
| loss on prepayment of senior notes | -2,058,250 | |||||||||||||||
| other loss | -499,000 |
We provide you with 20 years income statements for Assertio stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as earnings, sales and marketing expenses, research and development costs, profits, and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Assertio stock. Explore the full financial landscape of Assertio stock with our expertly curated income statements.
The information provided in this report about Assertio stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.